CHIRON |
Science
For Life
Hypotheses for TRAFFIC
Intra-arterial rFGF-2 improves exercise
capacity
in patients with intermittent claudication due to infra-inguinal
PAD
Repeat administration of rFGF-2 at 30 days is superior
to single administration
80% powered to detect a 60 increase
for SINGLE
and a 90 increase for DOUBLE